Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Precise Bio's retinal patch is a 3D/4D bioprinted tissue-engineered graft designed for the treatment of age-related macular degeneration (AMD). Utilizing an integrated 3D printing and tissue-engineering platform, the company produces bio-fabricated retinal tissue intended to replace or support damaged retinal pigment epithelium (RPE) and photoreceptors. The implant is surgically placed as a retinal graft or patch to preserve or restore vision in patients suffering from the breakdown of retinal tissue characteristic of AMD. While the company's lead program is a bioprinted cornea, the retinal patch is a key component of their ophthalmology pipeline aimed at regenerative medicine solutions for vision loss.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Precise Bio retinal patch.